IDEAS home Printed from https://ideas.repec.org/a/sae/medema/v32y2012i3p498-506.html
   My bibliography  Save this article

Patient and Other Factors Influencing the Prescribing of Cardiovascular Prevention Therapy in the General Practice Setting With and Without Nurse Assessment

Author

Listed:
  • Mohammed A. Mohammed
  • Charlotte El Sayed
  • Tom Marshall

Abstract

Background. Although guidelines indicate when patients are eligible for antihypertensives and statins, little is known about whether general practitioners (GPs) follow this guidance. Objective. To determine the factors influencing GPs decisions to prescribe cardiovascular prevention drugs. Design of Study. Secondary analysis of data collected on patients whose cardiovascular risk factors were measured as part of a controlled study comparing nurse-led risk assessment (four practices) with GP-led risk assessment (two practices). Setting. Six general practices in the West Midlands, England. Patients. Five hundred patients: 297 assessed by the project nurse, 203 assessed by their GP. Measurements. Cardiovascular risk factor data and whether statins or antihypertensives were prescribed. Multivariable logistic regression models investigated the relationship between prescription of preventive treatments and cardiovascular risk factors. Results. Among patients assessed by their GP, statin prescribing was significantly associated only with a total cholesterol concentration ≥7 mmol/L and antihypertensive prescribing only with blood pressure ≥160/100 mm Hg. Patients prescribed an antihypertensive by their GP were five times more likely to be prescribed a statin. Among patients assessed by the project nurse, statin prescribing was significantly associated with age, sex, and all major cardiovascular risk factors. Antihypertensive prescribing was associated with blood pressures ≥140/90 mm Hg and with 10-year cardiovascular risk. Limitations. Generalizability is limited, as this is a small analysis in the context of a specific cardiovascular prevention program. Conclusions. GP prescribing of preventive treatments appears to be largely determined by elevation of a single risk factor. When patients were assessed by the project nurse, prescribing was much more consistent with established guidelines.

Suggested Citation

  • Mohammed A. Mohammed & Charlotte El Sayed & Tom Marshall, 2012. "Patient and Other Factors Influencing the Prescribing of Cardiovascular Prevention Therapy in the General Practice Setting With and Without Nurse Assessment," Medical Decision Making, , vol. 32(3), pages 498-506, May.
    • Handle: RePEc:sae:medema:v:32:y:2012:i:3:p:498-506
    DOI: 10.1177/0272989X12437246
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/0272989X12437246
    Download Restriction: no
    File URL: https://libkey.io/10.1177/0272989X12437246?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Bryan, Stirling & Gill, Paramjit & Greenfield, Sheila & Gutridge, Kerry & Marshall, Tom, 2006. "The myth of agency and patient choice in health care? The case of drug treatments to prevent coronary disease," Social Science & Medicine, Elsevier, vol. 63(10), pages 2698-2701, November.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Zalika Klemenc‐Ketis & Alenka Terbovc & Bostjan Gomiscek & Janko Kersnik, 2015. "Role of nurse practitioners in reducing cardiovascular risk factors: a retrospective cohort study," Journal of Clinical Nursing, John Wiley & Sons, vol. 24(21-22), pages 3077-3083, November.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Emily Lancsar & Jordan Louviere, 2008. "Conducting Discrete Choice Experiments to Inform Healthcare Decision Making," PharmacoEconomics, Springer, vol. 26(8), pages 661-677, August.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:32:y:2012:i:3:p:498-506. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.